RNA Nanotherapeutics
PrivateLast Round
Grant
Oct 13, 2025
Total Funding Raised
$400,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
RNA Nanotherapeutics operates in Healthcare & Life Sciences and is based in Cincinnati, Ohio. Its latest recorded funding round was a Grant round in October 2025.
RNA Nanotherapeutics is a biotechnology company that develops cancer-targeting multifunctional RNA nanoparticles designed to improve therapeutic efficacy and reduce side effects in cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RNA Nanotherapeutics Comparables
Compare RNA Nanotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sixfold Bioscience | 88% | |
| RNA NanoBiotics, Inc. | 86% | |
| Kernal Biologics | 77% |
For institutional investors. Book with your work email.
RNA Nanotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 13, 2025 | ||||
| Grant | Jul 31, 2025 | ||||
| Grant | Oct 7, 2022 |
For institutional investors. Book with your work email.
RNA Nanotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Ohio Third Frontier | Grant |
| University of Cincinnati Venture Lab | Accelerator |
| Ohio's Entrepreneurial Services Provider Program | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 76% MoM, reaching 1K.
- Oct 13, 2025
$200K raised from Ohio Third Frontier.
For institutional investors. Book with your work email.
RNA Nanotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RNA Nanotherapeutics's valuation, stock price, and market status.
Is RNA Nanotherapeutics a public or private company?
RNA Nanotherapeutics is a private company.
What is the current stock price of RNA Nanotherapeutics?
RNA Nanotherapeutics is a private company, so its shares have no public market price. Caplight tracks RNA Nanotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RNA Nanotherapeutics worth (valuation)?
Valuation information for RNA Nanotherapeutics is not publicly available.
Can I buy RNA Nanotherapeutics stock?
RNA Nanotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RNA Nanotherapeutics's last funding round?
RNA Nanotherapeutics's most recent funding round was Grant on October 13, 2025.
Who are the main investors in RNA Nanotherapeutics?
Key investors in RNA Nanotherapeutics include National Cancer Institute, Ohio Third Frontier, University of Cincinnati Venture Lab, Ohio's Entrepreneurial Services Provider Program.
Will RNA Nanotherapeutics IPO soon?
No public IPO plans have been announced for RNA Nanotherapeutics.
How can I track RNA Nanotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in RNA Nanotherapeutics's shares on secondary markets.